“Whilst 2020 has provided the much-needed impetus for healthcare and life science customers to begin heavily investing in digital pathology, the market still has many challenges ahead. Questions such as ‘how will the pathology workflow evolve to incorporate digitisation?’ , ‘what will the infastructure requirements be for image management?’ and ‘how exactly will AI become incorporated and paid for?’ have yet to be fully addressed. The challenge now for vendors will be to address these questions head-on in order to make the transition as smooth as possible for adopters and by fully supporting them during this second wave.” Imogen Fitt, Report Author

Report Content


  • Identify the products and end-markets driving growth
  • Review the market drivers and barriers for growth
  • Quantitative analysis of market size and forecast growth


  • Market share estimates for the leading vendors
  • Data, analysis and commentary of investment and funding for new competitors from 2010-2021
  • Identify potential partners and acquisition targets


  •  Market analysis for core product segment and software product type
  • Details discussion on integration of Digital Pathology into broader healthcare
  • Impact of advanced machine learning and deep learning


  • Review of go-to-market strategies
  • Analysis and insights to support your strategy planning
  • Product pricing and software licensing strategies
Request Report Sample Related Content